Abstracts tagged "longitudinal studies and systemic sclerosis"

Abstract Number: 1734 • 2018 ACR/ARHP Annual Meeting
Association of Short-Term Longitudinal Changes in Clinical and Physiologic Variables with Overall Survival in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Vincent Sobanski¹, Jeska de Vries-Bouwstra², Anna-Maria Hoffmann-Vold³, Dörte Huscher⁴, Margarida Alves⁵, Marco Matucci-Cerinic⁶, Gabriela Riemekasten⁷, Mengtao Li⁸, Gabriele Valentini⁹, László Czirják¹⁰, Otylia Kowal-Bielecka¹¹, Yannick Allanore¹², Nils Schoof⁵ and Oliver Distler¹³, ¹Department of Internal Medicine and Clinical Immunology, University of Lille, Lille, France, ²Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ³Oslo University Hospital, Oslo, Norway, ⁴Charité – Universitaetsmedizin Berlin and Berlin Institute of Health, Berlin, Germany, ⁵Boehringer Ingelheim International GmbH, Ingelheim, Germany, ⁶Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy, ⁷Rheumatology, University Hospital Schleswig-Holstein - Campus Lübeck, Lübeck, Germany, ⁸Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, ⁹Department of Rheumatology, Second University of Naples, Napoli, Italy, ¹⁰Department of Rheumatology and Immunology, University of Pécs, Pécs, Hungary, ¹¹Department of Rheumatology and Internal Medicine, Medical University of Białystok, Białystok, Poland, ¹²Cochin Hospital, Paris Descartes University, Paris, France, Paris, France, ¹³Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland
Background/Purpose: Interstitial lung disease (ILD) is one of the leading causes of morbidity and mortality in patients with SSc. However, the impact of changes in…
Abstract Number: 1089 • 2014 ACR/ARHP Annual Meeting
Trajectories of Disability over Time Among Patients with Systemic Sclerosis
Sarah D. Mills¹, Rina S. Fox¹, Shadi Gholizadeh², Scott C. Roesch^1,3, Murray Baron^4,5, Marie Hudson^6,7, Russell Steele^6,8, Brett D. Thombs^6,9 and Vanessa L. Malcarne^1,10, ¹SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, ²Psychology, SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, ³Psychology, San Diego State University, San Diego, CA, ⁴Pavillion A, Rm 216, Jewish General Hospital, Montreal, QC, Canada, ⁵McGill University, Montreal, QC, Canada, ⁶Jewish General Hospital, Montreal, QC, Canada, ⁷Division of Rheumatology, McGill University, Montreal, QC, Canada, ⁸Mathematics, McGill University, Montreal, QC, Canada, ⁹Psychiatry, McGill University, Montreal, QC, Canada, ¹⁰San Diego State University, San Diego, CA
Background/Purpose Systemic Sclerosis (SSc) is often associated with disability, which worsens over time. However, there is considerable heterogeneity in the rate of patients’ disability progression.…
Abstract Number: 697 • 2013 ACR/ARHP Annual Meeting
Longitudinal Assessment Of Pulmonary Function In 304 Norwegian Patients With Systemic Sclerosis
Anna-Maria Hoffmann-Vold¹, Torhild Garen², Oyvind Midtvedt¹, May-Brit Lund³, Jan Tore Gran¹ and Øyvind Molberg⁴, ¹Rheumatology, Oslo University Hospital, Oslo, Norway, ²Department of Rheumatology, Oslo University Hospital Rikshospitalet, Oslo, Norway, ³Pulmonary Unit, Oslo University Hospital, Rikshopitalet, Oslo, Norway, ⁴Oslo University Hospital, Oslo, Norway
Background/Purpose: The purpose of this study was to asses sequential pulmonary function measurements (forced vital capacity [FVC] % predicted) in a large systemic sclerosis (SSc)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].